Long-term inhaled corticosteroid (ICS) use for chronic obstructive pulmonary disease/ COPD (lung disease) may increase the ...

Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as ...

Summary. Exacerbations of COPD are common and can be detrimental to both patient health and health care costs. Corticosteroids are recommended by consensus guidelines for patients during ...

For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is associated with increased rates of adverse composite and specific individual ...

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Steroids, or corticosteroids, are available orally, as an injection, and as a topical. However, they come with serious risks and side effects, such as diabetes and glaucoma. Rheumatoid arthritis ...

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung tissue.

The trial encompassed a broad range of COPD phenotypes and clinical presentations ... for use as an add-on treatment alongside intranasal corticosteroids for chronic rhinosinusitis with nasal ...

Mustafa and colleagues assessed 38 patients (median age, 65 years; 32% men) with COPD receiving triple therapy who had at least two exacerbations that required steroids or a hospitalization within ...

Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations ... reasonable to recommend oral corticosteroids when patient ...